Pfizer | PFE - Trade Creditors


Pfizer reported $4.58B in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Abbott USD 4.68B 439M Mar/2026
ALKERMES USD 142.86M 40.5M Jun/2026
Amgen USD 19.52B 1.37B Mar/2026
AstraZeneca USD 22.89B 388M Jun/2026
Bayer EUR 6.59B 496M Mar/2026
Biogen USD 403.9M 45.4M Jun/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Coherus Biosciences USD 9.91M 14.98M Dec/2025
Drreddys Laboratories INR 22.36B 21.91B Mar/2026
Eli Lilly USD 5.03B 350M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 7M Jun/2026
Glaxosmithkline GBP 14.34B 6.39B Mar/2026
J&J USD 9.22B 1.24B Jun/2026
Medtronic USD 2.57B 12M Dec/2025
Merck USD 3.86B 541M Mar/2026
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
Novartis USD 4.26B 64M Jun/2026
Novartis USD 4.32B 134M Mar/2026
Pacira USD 14.01M 1.14M Mar/2026
Perrigo USD 434.8M 39.7M Mar/2026
Pfizer USD 4.58B 75M Jun/2026
Phibro Animal Health USD 129.64M 3.65M Mar/2026
Prestige Brands USD 22.79M 20.15M Mar/2026
Regeneron Pharmaceuticals USD 1.16B 132.2M Jun/2026
Roche Holding CHF 5.54B 237M Jun/2026
Sanofi EUR 23.6B 888M Jun/2026
Sanofi EUR 22.71B 219M Mar/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026
Zoetis USD 507M 20M Mar/2026